Editorial of Special Issue "Multiple Sclerosis: Diagnosis and Treatment II"

被引:1
作者
Rivera, Victor M. [1 ]
机构
[1] Baylor Coll Med, Dept Neurol, One Baylor Plaza, Houston, TX 77030 USA
关键词
multiple sclerosis; acetylcholine; PBMCs; minority populations; spinal cord; sphingosine-1-phosphate modulators; neurofilaments light chain; biomarkers; microRNAs; child neurology;
D O I
10.3390/biomedicines9111605
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The special issue on Multiple Sclerosis: Diagnosis and Treatment II, reflects advances and discoveries in the molecular and cellular mechanisms of disease, and novel laboratory techniques providing more sensitivity to diagnostic techninques and the understanding of neuroinflammation. Mitochondrial-mediated apoptosis in isolated peripheral blood mononuclear cells and the role of reactive oxygen species are studied as indicators of activity of MS. In these cells, downregulation of circular and linera RNAs are reported as markers of highly active disease in MS. Progress and importance of Neurofilaments determinations in early diagnosis and as a marker of disease activity, and the analysis of the complex mechanisms and therapeutic potential of Sphingosine-1-phosphate receptor modulator are discussed. Epidemiologic observations from a highly diversified area of the world provide more insights into this important aspect of MS; discussions on the clinical challenges posed by spinal cord involvement in demyelinatind disorders and the latest aspects of pediatric onset MS, complement this fine collection of scientific papers.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Exploring the Pathophysiology, Diagnosis, and Treatment Options of Multiple Sclerosis
    Lorenzut, Simone
    Del Negro, Ilaria
    Pauletto, Giada
    Verriello, Lorenzo
    Spadea, Leopoldo
    Salati, Carlo
    Musa, Mutali
    Gagliano, Caterina
    Zeppieri, Marco
    JOURNAL OF INTEGRATIVE NEUROSCIENCE, 2025, 24 (01)
  • [32] Consensus recommendations for the diagnosis and treatment of multiple sclerosis in Kuwait
    Alroughani, R.
    Ashkanani, A.
    Al-Hashel, J.
    Khan, R.
    Thussu, A.
    Alexander, K. J.
    Vembu, P.
    Sharfuddin, K.
    Lamdhade, S.
    John, J. K.
    Alkhashan, S.
    Abualmelh, M.
    Al-Shammri, S.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 143 : 51 - 64
  • [33] General Approach to Diagnosis and Treatment of Multiple Sclerosis in Turkey
    Terzi, Murat
    Celik, Yahya
    Kilinc, Munire
    Seleker, Feray
    Isik, Nihal
    Gedizlioglu, Muhtesem
    Zorlu, Yasar
    TURKISH JOURNAL OF NEUROLOGY, 2009, 15 (03) : 124 - 128
  • [34] Potential application of hydrogel to the diagnosis and treatment of multiple sclerosis
    Haochuan Liu
    Bing Chen
    Qingsan Zhu
    Journal of Biological Engineering, 16
  • [35] Immunopathogenesis, Diagnosis, and Treatment of Multiple Sclerosis: A Clinical Update
    Perez, Carlos A.
    Cuascut, Fernando X.
    Hutton, George J.
    NEUROLOGIC CLINICS, 2023, 41 (01) : 87 - 106
  • [36] Alemtuzumab in the treatment of multiple sclerosis: patient selection and special considerations
    Doerr, Jan
    Baum, Karl
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3379 - 3386
  • [37] Insight into Early Diagnosis of Multiple Sclerosis by Targeting Prognostic Biomarkers
    Puranik, Nidhi
    Yadav, Dhananjay
    Song, Minseok
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (32) : 2534 - 2544
  • [38] Multiple sclerosis biomarkers: Helping the diagnosis?
    Thouvenot, E.
    REVUE NEUROLOGIQUE, 2018, 174 (06) : 364 - 371
  • [39] Editorial: Diet and multiple sclerosis
    Titcomb, Tyler J.
    Giesser, Barbara S.
    Plafker, Scott M.
    Sand, Ilana B. Katz
    Wahls, Terry L.
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [40] Editorial: Neuroplasticity in multiple sclerosis
    Yalachkov, Yavor
    Karimi-Abdolrezaee, Soheila
    Tavazzi, Eleonora
    FRONTIERS IN NEUROLOGY, 2025, 16